Skip to main content

Two medicines, side by side

Prednisolone vs naproxen

Prednisolone and naproxen are both labeled for osteoarthritis. Drugs@FDA records approvals of prednisolone since 1955 and of naproxen since 1976. Pharmacies paid $4.72 per mL (Prednisolone ac 1% eye drop) and $0.0565 per naproxen 500 mg tablet (NADAC, October 7, 2026); the strengths differ, so the two prices are not like for like. Prednisolone's other strengths are brand-only: $30.66 per mL (Pred mild 0.12% eye drops). In FDA's classes, prednisolone is a corticosteroid and naproxen a nonsteroidal anti-inflammatory drug.

Check it at the source: the prednisolone FDA label on DailyMed (effective June 25, 2026); the naproxen FDA label on DailyMed (effective March 12, 2026).

Highlights of the prednisolone record

Prednisolone (Pred) · label of June 25, 2026

Used for

From the label: indications

Prednisolone Sodium Phosphate Oral Solution is indicated in the following conditions: 1. Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adult and pediatric populations with: seasonal or perennial allergic rhinitis; asthma; contact dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity reactions. 2. […]

On the market

Earliest approval on file
May 22, 1955
Generic labelers
25 labelers
Pharmacy cost
$4.72 per mL

Supply and safety

Shortage
No current entry
Recalls
9

Highlights of the naproxen record

Naproxen (Aleve) · label of March 12, 2026

Used for

From the label: indications

temporarily relieves minor aches and pains due to: minor pain of arthritis muscular aches backache menstrual cramps headache toothache the common cold temporarily reduces fever

On the market

Earliest approval on file
March 11, 1976
Generic labelers
139 labelers
Pharmacy cost
$0.0565 per tablet

Supply and safety

Shortage
No current entry
Recalls
8

Source: FDA drug labels via openFDA (Prednisolone label of June 25, 2026, Naproxen label of March 12, 2026); NDC Directory, Drugs@FDA, NADAC, FDA shortages and recalls (October 8, 2026)

How do prednisolone and naproxen differ on the record?

In FDA's classes, prednisolone is a corticosteroid and naproxen a nonsteroidal anti-inflammatory drug.

Only the naproxen label carries a boxed warning.

Generics: prednisolone since 1971; naproxen since 1992 (Drugs@FDA).

PrednisoloneNaproxen
Labeled forAnemia, Leukemia, lymphoma and myeloma, Multiple sclerosis, Osteoarthritis, Asthma, Allergies, Herpes and shingles, Crohn's disease and ulcerative colitis, Eczema (atopic dermatitis), Organ transplant rejectionFever, Rheumatoid arthritis, Osteoarthritis, Gout, Pain, Cough and cold
Pharmacologic classCorticosteroidNonsteroidal Anti-inflammatory Drug
How it works (label)n/an/a
Half-life (label)Prednisolone is 70-90% protein-bound in the plasma and it is eliminated from the plasma with a half-life of 2 to 4 hours.n/a
Earliest approval on file (Drugs@FDA)May 22, 1955March 11, 1976
First generic approvedNovember 24, 1971October 30, 1992
Generic labelers (NDC)25 labelers139 labelers
Pharmacy cost (NADAC, each one's most listed form; strengths differ)$4.72 per mL (Prednisolone ac 1% eye drop)$0.0565 per tablet (Naproxen 500 mg tablet)
12-month price change+4%-9%
Boxed warningNoYes
Shortage nowNo current entryNo current entry
Recalls recorded98
FAERS reports (a report is not proof of cause; counts follow how widely a medicine is used)191,407142,225
DEA schedulenonenone

Source: Drugs@FDA, FDA NDC Directory, CMS NADAC of October 7, 2026, FDA shortages and recalls, FAERS via openFDA (FDA files October 8, 2026)

What do the labels say about using others of their kind?

Naproxen label, drug interactions (prescription label)

Concomitant use of naproxen with other NSAIDs or salicylates (e.g., diflunisal, salsalate) increases the risk of GI toxicity, with little or no increase in efficacy [ see Warnings and Precautions ( 5.2 ) ].

Source: FDA drug labels via openFDA

What next?

Alternatives to prednisolone
every medicine labeled for the same conditions